UPDF AI

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis.

B. Feagan,W. Sandborn,20 Authors,B. Levesque

2013 · DOI: 10.1053/j.gastro.2013.03.025
Gastroenterology · 209 Citations

TLDR

Although mesalamine 4.8 g/day was not statistically different from placebo for induction of remission in patients with mildly to moderately active UC, based on an intent-to-treat analysis, the totality of the data supports a benefit of treatment.